INFLAMMATORY AND CARDIAC BIOMARKERS AS PREDICTORS OF HIGH CARDIOVASCULAR RISK IN ADULTS OVER 30 YEARS OF AGE
Keywords:
Conventional 10-year scores underestimate risk in adults aged 30–50, so biomarkers that reflect the inflammatory and myocardial components of atherosclerosis are of growing interest.Abstract
Cardiovascular diseases (CVD) caused 18.6 million deaths worldwide in 2019. According to the revised WHO risk charts, the same risk profile corresponds to a 10-year risk of 11% in Andean Latin America and 30% in Central Asia, one of the highest-risk regions.
References
1. Ridker PM, Moorthy MV, Cook NR, et al. Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women. N Engl J Med. 2024;391(22):2087-97. doi:10.1056/NEJMoa2405182
2. Ridker PM, Bhatt DL, Pradhan AD, et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet. 2023;401(10384):1293-301. doi:10.1016/S0140-6736(23)00215-5
3. Evstifeeva SE, Shalnova SA, Kutsenko VA, et al. Association of high-sensitivity C-reactive protein with fatal and non-fatal cardiovascular events in working-age people: data from the ESSE-RF study. Russian Journal of Cardiology. 2021;26(5):4399. doi:10.15829/1560-4071-2021-4399
4. Willeit P, Welsh P, Evans JDW, et al. High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. J Am Coll Cardiol. 2017;70(5):558-68. doi:10.1016/j.jacc.2017.05.062
5. Willeit P, Kaptoge S, Welsh P, et al. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol. 2016;4(10):840-9. doi:10.1016/S2213-8587(16)30196-6
6. Adamstein NH, MacFadyen JG, Rose LM, et al. The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J. 2021;42(9):896-903. doi:10.1093/eurheartj/ehaa1034
